IRD ▼ -1.2% - Opus Genetics, Inc. $IRD - Opus Genetics Presents Positive Clinical Data from OPGx-BEST1 and OPGx-LCA5 Gene Therapy Programs at Retina in Rio 2026 15-OCT-2026 04:00 PM ET